Get an in-depth view of the attractive non-dilutive funding programs offered by CQDM which have supported several Ontario health science companies.

✓ Quantum Leap & SynergicQc Programs
✓ Application & Funding Process
✓ Mentorship & Large Pharma Partners

OBIO invites you to a unique opportunity to hear from Steve Xanthoudakis, Chief Business Development Officer at CQDM (Consortium Québécois sur la Découverte du Médicament). Steve will talk about their unique partnership with 10 large Pharma companies and CQDM’s non-dilutive funding programs which support development of platform technologies in the drug discovery and development space. Such opportunities are also open to Ontario companies.

This interactive workshop will start with a presentation by Steve that will also cover how best to engage with CQDM and highlight several current examples of Ontario companies obtaining funding from CQDM.